Anavex Life Sciences Corp (AVXL)

[F1ash]

Should they be?

Well from my limited experience with other biotechs, not raising as much money as possible before trial results was a mistake. Say for instance the trial results are disappointing, would that be a good time to have to raise more capital? If the trial succeeds, management could switch over to the more desirable Cantor ATM from the drip, drip LPC ELOC.